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Objective: This study sought to determine the antioxi-
dant activities of African birch leaf, to assess its interac-
tion with key enzymes relevant to type 2 diabetes (a-
amylase and a-glucosidase) and to evaluate its effect on
acarbose in vitro.
Methods: One milligram per milliliter of aqueous extract
of African birch and acarbose were separately prepared.
At the same time, both the African extract and acarbose
solution (50:50 v/v) were thoroughly mixed until homo-
geneity was attained. The phenolic phytoconstituents and
antioxidant properties of African birch leaf were subse-
quently determined. Finally, the effects of African birch
extract, acarbose solution and a mixture of acarbose and
African birch extract on a-amylase and a-glucosidase
activities were assessed in vitro.
Results: The results showed that African birch extract
demonstrated a remarkable antioxidant effect, as exempli-
fied by its radical scavenging abilities, Fe2þ chelating ability
and prevention of lipid peroxidation. Acarbose had signifi-
cantly (p< 0.05) higher a-amylase (IC50¼ 11.77 mg/ml) and
a-glucosidase (IC50 ¼ 9.05 mg/ml) activities compared to
African birch extract [a-amylase (IC50 ¼ 242.17 mg/ml); a-
glucosidase (IC50 ¼ 196.35 mg/ml)]. However, the combi-
nation of acarbose and African birch extract showed an
additive effect on a-amylase inhibition, while a resultant
synergistic action was observed against a-glucosidase
inhibition.y. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2016.03.001
S.A. Adefegha et al. 237Conclusion: The additive and synergistic actions of the
combination of African birch extract and acarbose solu-
tion suggest effective, complementary and alternative
strategies towards the management/treatment of hyper-
glycaemia associated with type 2 diabetes.
Keywords:African birch;Acarbose;a-Amylase;a-Glucosidase;
Leaf; Type 2 diabetes
 2016 The Authors.
Production and hosting by Elsevier Ltd on behalf of Taibah
University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Diabetes is a group of metabolic diseases characterized by
hyperglycaemia, which results from defects in insulin resis-
tance, insulin secretion and beta cell dysfunction.1 Of all of the
diagnosed cases of diabetes, NIDDM accounts for
approximately 90e95%.2 It has been linked to several risk
factors involving lifestyle, such as smoking, obesity, poor
diet and physical inactivity.3 a-Amylase and a-glucosidase
are critical enzymes involved in starch hydrolysis and are
implicated in the onset of type 2 diabetes (T2D).4 Pancreatic
a-amylase catalyzes the hydrolysis of starch to a mixture of
oligosaccharides and disaccharides, while intestinal a-
glucosidase breaks down disaccharides and oligosaccharides
into glucose which, upon absorption, enters the
bloodstream.5 Degradation of these complex carbohydrates
is very fast and may result in an elevated blood glucose level
after a meal.6 Synthetic oral antidiabetic agents such as
acarbose and miglitol elicit their therapeutic effects through
the inhibition of these enzymes, but their administration is
associated with serious side effects and a failure to alleviate
diabetic complications.7 Recently, interest in the use of
medicinal plants in the form of traditional medicine has
increased all over the world, especially in Africa, due to their
cheap cost, availability and effectiveness.8
Nigeria has a wide range of plant diversity, with great
potential of identifying plants of pharmacological relevance.
African birch (Anogeissus leiocarpus) (Family: Combretaceae)
is a tropical plant with large ecological distribution across
Africa.9 The plant parts (leaf, stem, bark and root) are used in
traditional medicine for the treatment of some ailments
because they have been reported to possess antimicrobial,
hepatoprotective and antioxidant properties.10,11 A previous
study by Etuk and Mohammed12 revealed a spontaneous
decrease in blood glucose levels in alloxan-induced diabetic
rats administered African birch extract. However, there is a
dearth of information on the possible mechanism by which
the plant elicits its antidiabetic effects.
Consequently, we aimed to assess the antioxidant activ-
ities and interaction between aqueous African birch leaf
extract with key enzymes linked to starch hydrolysis. Addi-
tionally, considering the combinatorial usage of traditional
plants and synthetic drugs in Nigeria, it is pertinent to
evaluate and compare the effects of this plant to acarbose (a
known antidiabetic drug) in vitro.Materials and Methods
Materials
Sample collection
African birch leaf was purchased from local traditional
healers at the Erekasan Market in Akure Metropolis of
Ondo State, Nigeria. Authentication of the plant was per-
formed by the Crop, Soil and Pest Management (CSP)
Department at the Federal University of Technology, Akure
(FUTA), Nigeria (Voucher specimen no: FUTA/HB/
0112AL1).
Chemicals and reagents
All chemicals and reagents used in this study were of
analytical grade, and glass-distilled water was used.
Aqueous extraction of African birch leaf and acarbose
African birch leaf was thoroughly washed under running
distilled water, air dried, ground into powder and kept dry in
an air-tight container prior to extraction according to the
method of Adefegha and Oboh.13 The sample (5 g) was
weighed, soaked in 100 ml of distilled water and left for
24 h. The mixture was filtered after 24 h and the filtrate kept
in a refrigerator below 0 C. The frozen extract solution was
recovered as dried extract under pressure of approximately
200e450 mbar at 40 C. The dried extract was reconstituted
in distilled water (1 mg/ml) and used for subsequent analysis.
Similarly, a stock concentration of 1 mg/ml acarbose was
prepared and later diluted for subsequent use.
Phenolic characterization
Determination of total phenolic content
Briefly, 1 mg/ml of extract was oxidized with 2.5 ml of
10% FolineCiocalteu’s reagent (v/v) and neutralized with
2.0 ml of 7.5% sodium carbonate. The reaction mixture was
incubated for 40 min at 45

C and absorbance was measured
at 765 nm using a UV/Visible Spectrophotometer, 6315 Se-
ries (Jenway, Chelmsford, Essex CM1 3UP, England). Total
phenolic content was subsequently calculated as the gallic
acid equivalent.14
Determination of total flavonoid content
Briefly, 0.5 ml of extract (1 mg/ml) was mixed with 0.5 ml
of methanol, 50 ml of 10% AlCl3, 50 ml of 1 M potassium
acetate and 1.4 ml of water and incubated at room temper-
ature for 30 min. Absorbance of the reaction mixture was
subsequently measured at 415 nm, and total flavonoid con-
tent was calculated and expressed as the quercetin
equivalent.15
Quantification of phenolic compounds by HPLC-DAD
Reverse phase chromatographic analyses were carried out
under gradient conditions using a C18 column
(4.6 mm 150 mm) packed with 5-mm diameter particles; the
mobile phase was water containing 1% formic acid (A) and
acetonitrile (B), and the composition gradient was as follows:
13% of B until10 min and then changed to obtain 20%, 30%,
50%, 60%, 70%, 20% and10% B at 20, 30, 40, 50, 60, 70 and
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Adefegha et al.,16 with slight modifications. African birch
extract and the mobile phase were filtered through a 0.45-
mm membrane filter (Millipore) and then degassed in an
ultrasonic bath prior to use. African birch extract was
analyzed at a concentration of 20 mg/ml. The flow rate was
0.7 ml/min, and the injection volume was 40 ml. The
wavelengths were 254 nm for gallic acid; 280 nm for
catechin and epicatechin; 325 nm for chlorogenic, caffeic
and ellagic acids; and 365 nm for quercetin, quercitrin,
rutin and kaempferol. All chromatography operations were
carried out at ambient temperature and in triplicate.
In vitro antioxidant studies
1,1-Diphenyl-2 picrylhydrazyl free radical scavenging ability
The free radical scavenging ability of the plant extract
against DPPH (1,1-diphenyl-2 picrylhydrazyl) was evaluated
as described by Gyamfi et al.17 Briefly, the extracts (0e
500 mg/ml) were mixed with 1 ml of 0.4 mM methanolic
solution containing DPPH radicals. The mixture was left in
the dark for 30 min and absorbance was read at 516 nm.
DPPH free radical scavenging ability was subsequently
calculated and expressed as a percentage (%).
Fenton reaction (degradation of deoxyribose)
The method of Halliwell and Gutteridge18 was used to
determine the ability of the plant extract to prevent the
Fe2þ/H2O2-induced decomposition of deoxyribose.
Extracts (0e347.83 mg/ml) were added to a reaction
mixture containing 120 ml of 20 mM deoxyribose, 400 ml of
0.1 M phosphate buffer and 40 ml of 500 mM FeSO4, and
brought to a final volume of 800 ml with distilled water.
The reaction mixture was incubated at 37 C for 30 min
and the reaction stopped by the addition of 0.5 ml of 2.8%
trichloroacetic acid. This was followed by the addition of
0.4 ml of 0.6% thiobarbituric acid solution. The tubes were
subsequently incubated in boiling water for 20 min and
absorbance was measured at 532 nm. The OH radical
scavenging ability was subsequently calculated and
expressed as a percentage (%).
Fe2þ chelation assay
The Fe2þ chelating ability of the extract was determined
using a modified method of Minotti and Aust.19 One
hundred fifty microliters of freshly prepared FeSO4
(500 mM) was added to a reaction mixture containing
168 ml of 0.1 M TriseHCl (pH 7.4), 218 ml of saline and
the extracts (0e200 mg/ml). The reaction mixture was
incubated for 5 min before the addition of 13 ml of 0.25%
1,10-phenanthroline (w/v). Absorbance was subsequently
measured at 510 nm in a Jenway UV/Visible
spectrophotometer, 6315 series. The Fe2þ chelating ability
was calculated and expressed as a percentage (%).
Lipid peroxidation and thiobarbituric acid reactions
Wistar rats were anaesthetized in mild diethyl ether, and
the pancreases were excised. Pancreatic tissue was rapidly
rinsed in saline, placed on ice and weighed. The tissue was
subsequently homogenized in cold saline (1/10 w/v) withapproximately 10 up-and-down strokes in a Teflon glass
homogenizer. The homogenate was centrifuged for 10 min at
3000 g to yield pellets that were discarded, and low-speed
supernatant (Sl) was obtained. The lipid peroxidation assay
was carried out using the modified method of Ohkawa et al.20
Briefly 100 ml of the S1 fraction was mixed with a reaction
mixture containing 30 ml of 0.1 M TriseHCl buffer (pH
7.4), extracts (0e312.50 mg/ml) and 30 ml of 250 mM freshly
prepared FeSO4. The volume was brought up to 300 ml
with distilled water before incubation at 37 C for 1 h. The
color reaction was developed by adding 300 ml of 8.1%
sodium dodecyl sulfate to the reaction mixture containing
S1. This was subsequently followed by the addition of
600 ml acetic acid/HCl (pH 3.4) and 600 ml of 0.8%
thiobarbituric acid. This mixture was incubated at 100 C
for 1 h and absorbance was read at 532 nm. Lipid
peroxidation was subsequently calculated as the amount of
malondialdehyde (MDA) produced (% of control).
Enzyme inhibition assay
a-Amylase assay
a-Amylase activity was determined according to the
method described by Worthington.21 African birch extract
(0e0.8 mg/ml) or acarbose (0e80 mg/ml) and 50 ml of
0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M
NaCl) containing Hog pancreatic a-amylase (EC 3.2.1.1)
(0.5 mg/ml) were incubated at 25 C for 10 min. Then,
50 ml of 1% starch solution in 0.02 M sodium phosphate
buffer (pH 6.9 with 0.006 M NaCl) was added to each
tube. The reaction mixtures were incubated at 25 C for
10 min and stopped with 100 ml dinitrosalicylic acid color
reagent. Thereafter, the mixture was incubated in a boiling
water bath for 5 min and cooled to room temperature. The
reaction mixture was then diluted by adding 1.0 ml distilled
water, and absorbance was measured at 540 nm. a-
Amylase inhibitory activity was subsequently calculated
and expressed as a percentage (%).
a-Glucosidase inhibition assay
a-Glucosidase activity was determined by the modified
method described by Oboh et al.4 Fifty microliters of African
birch extract (0e0.8 mg/ml) or acarbose (0e80 mg/ml) and
100 ml of a-glucosidase solution (1.0 U/ml) in 0.1 M
phosphate buffer (pH 6.9) were incubated at 25 C for
10 min. Then, 50 ml of 5 mM p-nitrophenyl-a-D-
glucopyranoside solution in 0.1 M phosphate buffer (pH
6.9) was added. The mixtures were incubated at 25 C for
5 min before reading the absorbance at 405 nm. a-
Glucosidase inhibitory activity was calculated and
expressed as percentage (%) inhibition.
Statistical analysis
The mean values from triplicate experiments were pooled
and expressed as the mean standard deviation (STD). One-
way analysis of variance was used to analyze the results.
Tukey’s test was used for the post hoc analysis, and the least
significance difference (LSD) was carried out. GraphPad
Prism 6 software was used for the analysis. The IC50 (extract
concentration causing 50% enzyme inhibitory/antioxidant
Table 2: Quantification of phenolic compounds by HPLC-
DAD in African birch leaf extract.
Compounds African birch LOD LOQ
mg/g % mg/mL mg/mL
Gallic acid 2.97  0.07e 0.29 0.019 0.067
Catechin 8.45  0.08c 0.84 0.024 0.081
Chlorogenic acid 27.19  0.04a 2.71 0.032 0.039
Caffeic acid 1.14  0.05g 0.11 0.015 0.049
Ellagic acid 3.08  0.08e 0.30 0.025 0.083
Epicatechin 3.17  0.06e 0.31 0.016 0.057
Rutin 5.43  0.10d 0.54 0.028 0.096
Quercitrin 1.36  0.04f 0.13 0.013 0.042
Quercetin 14.69  0.03b 1.46 0.009 0.027
Kaempferol 5.72  0.11d 0.57 0.034 0.112
Results are expressed as mean  standard deviations (SD) of
three determinations.
Values with different superscript alphabets (aeg) along the same
column are significantly (p < 0.01) different using the Tukey test.
Table 3: IC50 Values for the DPPH and OH radical scavenging
ability, Fe2D chelating ability, inhibition of FeSO4 induced
MDA production in rat’s pancreas in vitro, a-amylase and a-
glucosidase inhibitory activities of African birch and acarbose.
Assays Samples
African birch (mg/ml) Acarbose (mg/ml)
DPPH 348.25  3.83 N.D
OH 183.14  4.16 N.D
Iron chelation 187.45  3.82 N.D
Lipid peroxidation 174.00  2.78 N.D
a-Amylase 242.17  4.20* 11.77  1.25**
a-Glucosidase 196.35  3.30* 9.05  1.33**
Values representmeans standard deviationof triplicate readings.
Values with asterisk (*) and (**) along the same row are signifi-
cantly different (p < 0.05).
N.D; Not determined.
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Results
Spectrophotometric and HPLC-DAD analysis of phenolics
in African birch extract
Table 1 lists the total phenolic contents of African birch
leaf. The results show a total phenolic content of 6.87 mg
GAE/g and a total flavonoid content of 4.38 mg QUE/g.
Furthermore, HPLC-DAD analysis was performed on
African birch leaf extract to identify and quantify the
presence of phenolic acids and flavonoids (Figure 5). The
results indicate that the plant extract contains chlorogenic
acid (27.19  0.04 mg/g) and quercetin (14.69  0.03 mg/g)
as the predominant phenolic compounds. Other phenolic
compounds found in African birch include catechin
(8.45  0.08 mg/g), kaempferol (5.72  0.11 mg/g), rutin
(5.43  0.10 mg/g), epicatechin (3.17  0.06 mg/g), ellagic
acid (3.08  0.08 mg/g), gallic acid (2.97  0.07 mg/g),
quercitrin (1.36  0.04 mg/g) and caffeic acid
(1.14  0.05 mg/g) (Table 2).
Antioxidant properties of African birch extract
The free radical scavenging ability of the sample was
assessed and the IC50 values are presented in Table 3. The
results showed that the leaf extract (IC50 ¼ 348.25 mg/ml)
scavenged DPPH. Additionally, the OH* scavenging ability
of the plant sample was determined; the plant extract
(IC50 ¼ 183.14 mg/ml) scavenged OH. In a similar manner,
the plant chelated Fe2þ with an IC50 value of 187.45 mg/ml.
Incubation of pancreas homogenates in the presence of
Fe2þ caused a significant increase (p < 0.05) in MDA
content. However, African birch extract inhibited MDA
production with an IC50 value of 174.00 mg/ml, as
presented in Table 3.
a-Amylase and a-glucosidase inhibitory activities
The a-amylase inhibitory properties of acarbose and Af-
rican birch extract were assessed and are presented in
Figure 1. The results revealed that both acarbose and the leaf
extract inhibited a-amylase activity in a concentration-
dependent manner. Acarbose (IC50 ¼ 11.77 mg/ml) had a
significantly (p < 0.05) higher a-amylase inhibitory effect
than African birch extract (IC50¼ 242.17 mg/ml). The in vitro
effect of the combination of African birch leaf extract with
acarbose on a-amylase inhibitory activities was also inves-
tigated (Figure 2). Combination of the synthetic drugTable 1: The total phenol and flavonoid content of African birch
leaf.
Phenolic contents African birch
Total phenolic (mg/GAE g) 6.87  0.45
Total flavonoid (mg/QUE g) 4.38  0.33
Figure 1: Inhibition of a-amylase activities (%) by African birch
leaf extract and acarbose. The concentrations of the extract used
for the plot are 0.00, 0.20, 0.40, 0.6 and 0.80 mg/mL for the values
0, 1, 2, 3 and 4 respectively as indicated on the x-axis of the graph.
The concentrations of the acarbose used for the plot are 0.00,
20.00, 40.00, 60.00 and 80.00 mg/mL for the values 0, 1, 2, 3 and 4
as shown on the x-axis of the graph. Values represent mean of
standard deviation of triplicate readings.
Figure 2: Inhibition of a-amylase activities (%) by African birch
leaf extract, combination of African birch leaf extract (50%) and
acarbose (50%) and acarbose alone. Different asterisks [(*) (**)
(***)] on bar chart indicate significant (p < 0.05) difference be-
tween African birch leaves, acarbose and mixture of acarbose and
African birch.
Figure 4: Inhibition of a-glucosidase activities (%) by African
birch leaf extract, combination of African birch leaf extract (50%)
and acarbose (50%) and Acarbose alone. (*) on the bar chart
indicates non significant (p > 0.05) difference.
Antioxidant and antidiabetic potentials of African birch leaf240(acarbose) and traditional plant (African birch leaf) resulted
in a significant (p < 0.05) increase in a-amylase inhibitory
activity compared with the plant extract only and synthetic
drug (acarbose) only. Likewise, the a-glucosidase
inhibitory abilities of the plant, acarbose and their
combination are presented in Figures 3 and 4, and IC50
values are listed in Table 3. The results revealed that
acarbose (IC50 ¼ 9.05 mg/ml) had significantly (p < 0.05)
higher a-glucosidase inhibitory activity than African birch
extract (IC50 ¼ 196.35 mg/ml). Additionally, the
combination of African birch extract and acarbose (50:50
v/v) did not cause a significant (p > 0.05) change in a-
glucosidase inhibitory activity compared with African birch
only and acarbose only.Figure 3: Inhibition of a-glucosidase activities (%) by African
birch leaf extract and acarbose. The concentrations of the extract
used for the plot are 0.00, 0.20, 0.40, 0.6 and 0.80 mg/mL for the
values 0, 1, 2, 3 and 4 respectively as indicated on the x-axis of the
graph. The concentrations of the acarbose used for the plot are
0.00, 20.00, 40.00, 60.00 and 80.00 mg/mL for the values 0, 1, 2, 3
and 4 as shown on the x-axis of the graph. Values represent mean
of standard deviation of triplicate readings.
Figure 5: Representative high performance liquid chromatog-
raphy profile of African birch leaf. Gallic acid (peak 1), catechin
(peak 2), chlorogenic acid (peak 3), caffeic acid (peak 3), ellagic
acid (peak 5), epicatechin (peak 6), rutin (peak 7), quercitrin (peak
8), quercetin (peak 9) and kaempferol (peak 10).Discussion
Total phenolic and flavonoid contents
One of the most abundant antioxidants in plants is
polyphenols, which are widely distributed across several food
products such as herbs, vegetables, cereals, olive, dry le-
gumes, chocolate and beverages.22 In this study, the total
phenol content of African birch was lower than that
reported in a previous study from our laboratory on
Crassocephalum crepidioides leaf, but it had a higher total
flavonoid content than that of C. crepidioides.23
Additionally, the phenolic content of African birch was
significantly (p < 0.05) higher than that of Celosia spp, as
reported by Molehin et al.24Antioxidant properties of African birch leaf
Growing scientific evidence suggests that an excess of
highly reactive free radicals, largely due to hyperglycaemia,
S.A. Adefegha et al. 241causes oxidative stress, which further elevates the develop-
ment and progression of diabetic complications.25 The use of
antioxidant supplementation in reducing the level of
oxidative stress and in slowing or preventing the
development of complications associated with diseases have
shown promising therapeutic effects.4,5,16,26 Many synthetic
antioxidant components have shown toxic and/or
mutagenic effects. Hence, much attention has been given to
naturally occurring antioxidants.26 Numerous plant
constituents have shown free radical scavenging or
antioxidant activity.14,23,24,26 The free radical scavenging
abilities, prevention of iron chelating ability and lipid
peroxidation (Table 3) exhibited by African birch may be
part of the mechanism through which African birch leaf
exerts its biological activities, which may be responsible for
its use in folkloric medicine as an antidiabetic agent.
Effect of African birch leaf extract on the inhibitory
properties of acarbose against a-amylase and a-glucosidase
activities
The inhibition of a-amylase and a-glucosidase activities
by African birch extract suggests the scientific basis for its
folkloric use in the management/treatment of diabetes and
could be of great importance in the development of a modern
therapeutic in the management of T2D.4,16 Furthermore,
chlorogenic acids and quercetin were abundant compared
with other phenolics found in African birch leaf. A recent
report showed that caffeic and chlorogenic acids are good
inhibitors of a-amylase and a-glucosidase activities.27
Therefore, we suggest that the inhibition of a-amylase and
a-glucosidase activities by plants and plant foods may be
attributed to their phenolic constituents.23,27 This agrees
with some studies where the inhibition of key enzymes (a-
amylase and a-glucosidase) relevant to T2D by plants has
been suggested as a therapeutic approach in the
management of this disease, and some vital bioactive
compounds, including polyphenols, may possess interesting
structure-function benefits and promising potential.5,16 The
increased inhibition in a-amylase activity by acarbose and
African birch extract when combined (50:50) resulted in an
additive effect (Figure 2), whereas the combination of both
acarbose and leaf extract caused a synergistic effect on
their inhibition of a-glucosidase in vitro (Figure 4). The
herbefood interaction may have a beneficial effect by
increasing drug efficacy or diminishing potential side
effects, as this was validated in our results (Figures 2 and
4). Findings from this study correlate with those from an
earlier study by Boath et al.,22 who affirmed that synergies
between acarbose and berry extracts in diabetes treatment/
management may enhance the hypoglycaemic effect and
the inhibition of a-glucosidase activity.
Conclusion
This study reports the antioxidant activities of African
birch leaf and the additive actions and synergistic interaction
between African birch leaf and acarbose in inhibiting a-
amylase and a-glucosidase activities, respectively. However,
these effects could be attributed to some phenolic compo-
nents in African birch leaf.Conflict of interest
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